Ask your competent? doctor and hospital when this testing will occur on stroke survivors.
Are you impressed with your doctors' world class incompetence with their head up their asses? Planning on doing anything about it, like getting them fired?
Noninvasive magnetic field therapy shows promise for long COVID cognitive impairment
A twice-weekly, at-home transcranial magnetic field intervention was associated with improvements in working memory, verbal learning, processing speed, and emotional well-being in patients with cognitive impairment associated with long COVID, according to a triple-blind pilot randomised controlled trial published in Brain Communications.
The findings represent the first randomised controlled trial of Microtesla Magnetic Therapy (MMT) for long COVID cognitive impairment, providing early evidence that noninvasive biophysical approaches may warrant further study as potential treatments for persistent neurological symptoms following severe acute respiratory syndrome coronavirus 2 infection.
Cognitive impairment -- often described as "brain fog" -- is among the most disabling manifestations of long COVID and is thought to involve sustained neuroinflammation, cerebrovascular dysfunction, and mitochondrial impairment.
Jacqueline Becker, PhD, Icahn School of Medicine at Mount Sinai, New York, New York, and colleagues randomised 30 adults with confirmed long COVID cognitive impairment 2:1 to active or sham MMT. Participants self-administered 15-minute at-home sessions twice weekly for 4 weeks, with remote monitoring, via a head-worn device delivering either a nonthermal radiofrequency magnetic field to the whole brain. Sham devices were identical in appearance and sound. Cognitive function, mood, and quality of life were assessed at baseline, week 4 (end of treatment), and week 8 (follow-up).
Adherence was 100% among participants who completed the study, and no device-related adverse events occurred. Compared with the sham group, active MMT was associated with significantly greater improvement at week 8 in Digit Span Sequencing (P = .026), Hopkins Verbal Learning Test-Revised Total Recall (P = .044), and Delis-Kaplan Executive Function System Color Naming (P = .049). Greater improvement on emotional well-being on the 36-Item Short Form Survey was also observed with active treatment (P = 0.017), and several measures continued to improve between weeks 4 and 8.
"Cognitive symptoms are among the most persistent and disabling manifestations of long COVID, yet evidence-based treatment options have been sparse," said Dr Becker. "What is particularly encouraging about these findings is that we observed improvements across several cognitive domains, as well as in daily functioning and well-being, and that these improvements persisted even after treatment ended."
"There is an urgent need to find answers and effective treatments for the hundreds of millions of people worldwide who are struggling with long COVID," said David Putrino, PhD, Icahn School of Medicine at Mount Sinai, New York, New York. "This first-in-human study is a promising start for a completely novel therapy that is showing great potential."
The authors emphasised that MMT remains investigational; they called for larger, adequately powered trials to confirm these preliminary findings and to examine the biological mechanisms underlying the observed effects.
Reference: https://academic.oup.com/braincomms/advance-article/doi/10.1093/braincomms/fcag364/8841135
SOURCE: Icahn School of Medicine at Mount Sinai
No comments:
Post a Comment